8-K
filed September 26, 2024, 7:59 PM ET
ticker AIXC
CIK 0001460702
other material
confidence high
sentiment negative
materiality 0.70
Qualigen CEO and CFO resign over disagreements; Board appoints interim CEO/CFO and President
AIxCrypto Holdings, Inc.
- Michael Poirier (CEO/Chairman) and Christopher Lotz (CFO) resigned immediately on Sep 23, 2024, citing disagreements over company's future direction.
- Board appointed Campbell Becher as President on Sep 25, 2024, effective immediately.
- Board appointed Kevin Richardson II as Interim CEO and Interim CFO on Sep 26, 2024; consulting fee $4,500 per week.
- Richardson previously served as CEO of Sanuwave Health, taking it from startup to $20M in revenue.
- Audit, Compensation, and Nominating committees reconstituted: Korenberg (Audit chair), Price (Comp chair), Lim (Nominating chair).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christopher Lotz resigned as Chief Financial Officer at AIxCrypto Holdings, Inc..
- Action
- resigned
- Role
- Chief Financial Officer
Exact text from the filing
Mr. Christopher Lotz, Chief Financial Officer of the Company, also tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Campbell Becher was appointed as President at AIxCrypto Holdings, Inc..
- Action
- appointed
- Role
- President
Exact text from the filing
the board of directors (the “Board”) appointed Campbell Becher as President of the Company, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kevin Richardson II was appointed as Interim Chief Executive Officer and Interim Chief Financial Officer at AIxCrypto Holdings, Inc..
- Action
- appointed
- Role
- Interim Chief Executive Officer and Interim Chief Financial Officer
Exact text from the filing
the Board of Directors appointed Kevin Richardson II as the Interim Chief Executive Officer and Interim Chief Financial Officer, as well as a member of the board of directors of the Company (the “Interim CEO and CFO”), effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Poirier resigned as Chief Executive Officer and Chairman at AIxCrypto Holdings, Inc..
- Action
- resigned
- Role
- Chief Executive Officer and Chairman
Exact text from the filing
Mr. Michael Poirier, Chief Executive Officer and Chairman of the board of directors of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kevin Richardson II was appointed as Director at AIxCrypto Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
as well as a member of the board of directors of the Company
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.